Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoxic pulmonary vasoconstriction.

J P Dumas1, M Bardou, F Goirand

  • 1Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Expérimentales, Faculté de Médecine, Dijon, France.

General Pharmacology
|October 16, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Targeting the TGF-β pathway in pulmonary fibrosis: Is it still a relevant strategy?]

Revue des maladies respiratoires·2025
Same author

Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

[HSP27: A new target for treating idiopathic pulmonary fibrosis?]

Revue des maladies respiratoires·2020
Same author

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.

European journal of medical genetics·2018
Same author

Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.

Cell death & disease·2016
Same author

Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.

Alimentary pharmacology & therapeutics·2014
Same journal

Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin.

General pharmacology·2002
Same journal

Reversal of hypercapnia induces endothelin-dependent constriction of basilar artery in rabbits with acute metabolic alkalosis.

General pharmacology·2002
Same journal

Reversal of hypercapnia induces KATP channel and NO-independent constriction of basilar artery in rabbits with acute metabolic alkalosis.

General pharmacology·2002
Same journal

Contractile responses in spontaneously diabetic mice. II. Effect of cholestyramine on enhanced contractile response of aorta to norepinephrine in C57BL/KsJ (db/db) mice.

General pharmacology·2002
Same journal

Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice.

General pharmacology·2002
Same journal

Investigation of basal endothelial function in the obese Zucker rat in vitro.

General pharmacology·2002
See all related articles

Hypoxic vasoconstriction uniquely regulates pulmonary blood flow. In disease, it causes pulmonary hypertension, but ion channel modulation offers new therapeutic targets for treatment.

Area of Science:

  • Pulmonary circulation physiology
  • Cardiovascular research
  • Respiratory medicine

Background:

  • Hypoxic vasoconstriction is a unique pulmonary circulation mechanism.
  • It balances ventilation and perfusion but can cause pulmonary hypertension in disease.
  • Vasoactive substances and ion channels are implicated in hypoxic pulmonary vasoconstriction.

Purpose of the Study:

  • To explore the mechanisms of hypoxic pulmonary vasoconstriction.
  • To review the role of vasoactive substances and ion channels.
  • To discuss current and emerging therapies for pulmonary hypertension.

Main Methods:

  • Review of existing literature on hypoxic pulmonary vasoconstriction.
  • Analysis of the roles of endothelial-derived vasoactive substances.

Related Experiment Videos

  • Examination of O2-sensitive ion channel activity in pulmonary vessels.

    • Main Results:

    • Hypoxic pulmonary vasoconstriction is modulated by ion channels (K+ and Ca2+), affecting different vessel types.
    • Inhaled vasodilators like prostacyclin and iloprost show efficacy in severe pulmonary hypertension.
    • Therapies targeting structural remodeling are experimental, but potassium channel openers and endothelin receptor antagonists are promising.

    Conclusions:

    • Ion channel modulation is key to hypoxic pulmonary vasoconstriction's self-regulatory function.
    • Inhaled vasodilators offer a new strategy for severe pulmonary hypertension.
    • Further research into novel drug targets is crucial for treating pulmonary hypertension and its vascular remodeling.